Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

DGMT CTP ecNGS supplies

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Food and Drug Administration is forecasting a future procurement for DGMT CTP ecNGS supplies under project E07877.01, with a posted date of May 25, 2026. This opportunity falls under NAICS code 325414, which corresponds to the manufacturing of pharmaceutical preparations, indicating the nature of the supplies being sought relates to laboratory or diagnostic testing reagents or materials used in next-generation sequencing. The contract action is currently listed as a forecast, meaning it is not yet solicited, and no solicitation number or set-aside details have been provided. The place of performance and office address information are not specified, suggesting the location may be flexible or determined during the formal procurement process. The point of contact for this opportunity is the NCTR Acquisition Liaison, reachable at nctracquisitions@fda.hhs.gov, who serves as the primary liaison for program-related inquiries. The Contracting Officer position has not yet been assigned, with contact details listed as to be determined. This forecast serves as an early notification to potential vendors interested in supplying specialized materials for the FDA’s laboratory and research operations, allowing industry to prepare for upcoming bidding opportunities. Interested parties should monitor the official HUD OSDBU portal at the provided link for future updates, including the release of a formal solicitation, anticipated timelines, and any additional requirements.

General Info

DGMT CTP ecNGS supplies forecast procurement by FDA under NAICS 325414, posted March 2026.

Agency

Food and Drug Administration → Food And Drug Administration

NAICS

325414 - Biological Product (except Diagnostic) ManufacturingView NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyFood and Drug Administration → Food And Drug Administration
Contacts2 people available
OfficeN/A
Organization / Agency
Food and Drug Administration → Food And Drug Administration
Office AddressN/A
Contacts
Nctr Acquisition Liaison
To Be Determined To Be DeterminedContracting Officer

Full Description

Show more
DGMT CTP ecNGS supplies project E07877.01

Similar Contracts

Same NAICS industry code

NAICS: 325414
New
Federal
Production of 4,000 Final Lateral Flow StripsThe contract requires the manufacture of 4,000 final lateral flow strips for pre-clinical testing, strictly adhering to a validated design and specifications set by the Centers for Disease Control and Prevention. The work must be performed in compliance with all technical and quality requirements established by the CDC to ensure the strips are suitable for intended pre-clinical use. The project is classified as a subcontract under NAICS code 325414, which corresponds to pharmaceutical and biological product manufacturing, indicating the need for specialized expertise in diagnostic device production. The place of performance is designated as Atlanta, Georgia, with the final deliverables expected to meet CDC’s rigorous standards for accuracy, consistency, and functionality. The solicitation was posted on July 24, 2026, with a response deadline of July 29, 2026, at 7:00 PM Eastern Time, leaving a limited window for qualified vendors to submit proposals. The contracting agency is the CDC Office of Acquisition Services under the Department of Health and Human Services, underscoring the public health significance of the project. While no set-aside provisions or specific organization type requirements are noted, bidders must be prepared to demonstrate capacity, regulatory knowledge, and quality control processes capable of delivering precisely specified diagnostic strips under a tight timeframe. The opportunity is accessible through the SAM.gov platform, and full compliance with CDC guidelines is non-negotiable for contract award.
CDC Office Of Acquisition Services

POSTED

2 days ago

DEADLINE

in 3 days
View Details
NAICS: 325414
New
DIBBS
Medical Supply Kit Manufacturing and AssemblyThe contract requires the manufacture, assembly, and packaging of a sterile epidural anesthesia set comprising 29 components, including a catheter and Tuohy needle, all of which must meet stringent DLA standards and applicable medical device regulations. The product must be produced in a controlled environment to ensure sterility and compliance with federal medical device requirements, with final packaging and labeling adhering to specified technical and regulatory guidelines. The work must be completed and delivered according to strict timelines, with the place of performance designated at JBER, Alaska, and all materials and processes subject to inspection and validation by the contracting authority. This is a subcontract under the Department of Defense’s Medical Supply Chain, managed by the MEDICAL SUPPLY CHAIN MD SURG FSF, and is classified under NAICS code 325414 for medical supplies and equipment manufacturing. The solicitation was posted on July 22, 2026, with responses due by July 28, 2026, indicating a narrow window for submission. Interested parties must ensure full alignment with DLA specifications and be prepared to provide documentation demonstrating regulatory compliance, quality control procedures, and capability to deliver the complete kit as specified. Failure to meet any requirement may result in disqualification or noncompliance penalties.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

4 days ago

DEADLINE

in 2 days
View Details
NAICS: 325414
New
International
Emergency Medical Supplies ProvisionThe contract pertains to the supply of essential medical materials including first aid kits, trauma dressings, personal protective equipment such as gloves, masks, and gowns, along with other medical consumables required for disaster response operations at Victoria Jubilee Hospital. These supplies are critical for ensuring immediate medical care during emergencies and must meet established standards for functionality, durability, and sterility to support effective response protocols. The procurement is structured as a subcontract under the broader emergency preparedness framework managed by the Kingston Public Hospital on behalf of the Government of Jamaica. Solicitation for this contract was posted on July 22, 2026, with a firm deadline for submissions set for July 27, 2026, at 8:00 PM, indicating a tight turnaround to address urgent operational needs. The North American Industry Classification System code 325414 identifies the sector as the manufacture of medical and surgical equipment and supplies, aligning with the nature of the requested products. All provisions are to be delivered to the designated facility in Jamaica, with no additional details on geographic distribution or logistics provided. Interested parties must submit proposals through the official electronic procurement portal linked in the contract data to be considered for award.
Kingston Public Hospital

POSTED

4 days ago

DEADLINE

in about 21 hours
View Details
NAICS: 325414
New
Federal
Supply of Blood Components and ProductsThe contract entails the supply of whole blood and its derived components—including red blood cells, platelets, plasma, and cryoprecipitate—to Veterans Affairs medical centers, requiring full compliance with FDA and AABB standards throughout every stage of collection, testing, processing, and labeling. All activities must adhere to rigorous quality and safety protocols to ensure the integrity and suitability of blood products for patient transfusion, with strict attention to inventory management, chain of custody, and product traceability. The successful bidder must demonstrate consistent capacity to meet the VA’s operational demands while maintaining compliance with federal regulations and industry best practices. This subcontract is issued under the 252-NETWORK Contract Office 12 (36C255) of the Department of Veterans Affairs and falls under NAICS code 325414, which designates the manufacturing of biological products, excluding pharmaceuticals. The opportunity was posted on July 22, 2026, with a firm response deadline of August 21, 2026, at 5:00 p.m. The place of performance and specific delivery locations are not detailed in the provided data, but fulfillment is expected to support VA facilities nationwide. The contract requires a robust logistical and manufacturing infrastructure to handle the time-sensitive nature of blood component distribution while ensuring seamless integration into VA’s existing transfusion services.
252-NETWORK Contract Office 12 (36C252)

POSTED

4 days ago

DEADLINE

in 26 days
View Details